- Vouliez-vous dire
- virus vaccines
Résultats de la recherche - 267 results
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksAbstract
brengen Service: Maladies virales Virale ziekten Viral diseases Manuscript versions: DOI: https://sciensano.be/en/10.1038/s43587-023-00421-1 Version: Published Full text access: Public Access Full text ...
Bulletin infections respiratoires aiguës semaine 28-2024- Publié 17/07/24
Infection respiratoire aiguë Service: Épidémiologie des maladies infectieuses Epidemiologie van infectieziekten Epidemiology of infectious diseases Maladies virales Virale ziekten Viral diseases Étude des ...
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
Publication Type: Peer reviewed scientific article Authors: Ingrao, Fiona; Ngabirano, Eva; Rauw, Fabienne; Dauphin, Gwenaëlle; Bénédicte Lambrecht * Source: Vaccine (2024) Abstract: The application ...
Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.
or 25 weeks of age, depending on the vaccination schedule. The analysis of viral transmission after homologous challenge showed that sentinels vaccinated with 2 doses with adjuvant were fully protected ...
Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm.
Koenraad; Willocx, Marie Source: Drug Test Anal (2023) Abstract: In 2019, a global viral pandemic, due to the SARS-CoV-2 virus, broke out. Soon after, the search for a vaccine and/or antiviral medicine began. ...
Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.
Kantele, Anu Source: Clin Microbiol Infect, Volume 29, Issue 12 (2023) Keywords: ADOLESCENT Adult Antibodies, Bacterial Double-Blind Method Hepatitis A Hepatitis A Antibodies Hepatitis A Vaccines Humans ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
(2023) Keywords: Alpha COVID-19 Delta Vaccine effectiveness Health Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Service: Maladies virales Virale ziekten ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
hospital study team Source: Eurosurveillance, Volume 28, Issue 47 (2023) Keywords: COVID-19 Omicron Vaccine effectiveness Service: Maladies virales Virale ziekten Viral diseases Épidémiologie des maladies ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
study teams (in addition to the named authors) Source: Euro Surveill, Volume 28, Issue 47 (2023) Keywords: Adult BNT162 Vaccine COVID-19 Europe Hospitalization Humans RNA, Viral SARS-CoV-2 Vaccine ...
Complete genome reconstruction of the global and European regional dispersal history of the lumpy skin disease virus.
circulation of vaccine-like recombinants, and the use of vaccines. The slow molecular evolution of its DNA genome limits the utility of genetic variation for accurate tracing based on evolutionary analyses, but ...